Tag: biomedical
-
RNA Treatment Tested for West Nile Virus
A therapy for West Nile Virus made with interfering RNA molecules is shown in lab mice to reduce viral loads, including in the brain where the disease can do serious damage.
-
Drug Shown Able to Kill Malaria-Carrier Mosquitoes
A clinical trial in Kenya shows blood from people who take a current anti-parasite drug can kill mosquitoes carrying malaria, offering a potential new strategy for controlling this disease.
-
FDA Authorizes Interoperable Glucose Monitoring System
The Food and Drug Administration authorized a device that electronically monitors blood glucose levels in people with diabetes, but is also designed to exchange data with other compatible electronic systems.
-
Paper Art Form Boosts Bandage, Wearables Adhesion
An engineering lab adapted the traditional Japanese art form of kirigami to create a surface for bandages and wearable devices on knees and elbows that bend a great deal and thus are difficult to stay on.
-
Patent Awarded for Nanoparticle Drug, Cannabis Delivery
A delivery technology for therapeutic compounds in nanoscale natural oil particles received a U.S. patent, which the company owning the technology says can be applied to drugs, nutritional supplements, and cannabis-based treatments.
-
Crowdsourced Project Building Whole Beta Cell Model
A new initiative is seeking participants from the worldwide research community to develop a multi-dimensional online model of the beta cell that produces insulin, found in the pancreas.
-
Crispr Enhanced to Find, Edit Tiny Mutations
A bioengineering lab at Harvard University designed a refinement for genome editing to identify and remove small genetic mutations that can lead to diseases or organisms resistant to current drugs.
-
Nerve Stimulation Device Being Tested for Arthritis
A device sending electrical pulses through a main nerve pathway is starting a clinical trial to test the device in people with rheumatoid arthritis, an autoimmune disease affecting joints and surrounding tissue.
-
High False-Positive Rate Found in Consumer Genetic Tests
Follow-up reviews of results from direct-to-consumer genetic tests show 40 percent of the actionable gene variations reported in the tests, including some indicating disease risk, were erroneous.
-
Immune Disease Precision Therapy Company Starts Up
An enterprise to discover biomarkers and precise treatments for individuals with immune system disorders is starting up, founded by six researchers in the U.S. and Europe.